位置:首页 > 蛋白库 > MILR1_MOUSE
MILR1_MOUSE
ID   MILR1_MOUSE             Reviewed;         246 AA.
AC   Q3TB92; B2RTB7; B7ZP18; D6RUW9; Q3TC23; Q3TDY5; Q3U5M7; Q3U9F5;
DT   23-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   23-OCT-2007, sequence version 2.
DT   03-AUG-2022, entry version 127.
DE   RecName: Full=Allergin-1;
DE   AltName: Full=Allergy inhibitory receptor 1;
DE   AltName: Full=Mast cell antigen 32;
DE            Short=MCA-32;
DE            Short=Mast cell Ag-32;
DE   AltName: Full=Mast cell immunoglobulin-like receptor 1;
DE   Flags: Precursor;
GN   Name=Milr1; Synonyms=Gm885, Mca32;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, DISRUPTION PHENOTYPE,
RP   SUBUNIT, SUBCELLULAR LOCATION, INTERACTION WITH PTPN6; PTPN11 AND INPP5D,
RP   TISSUE SPECIFICITY, GLYCOSYLATION, PHOSPHORYLATION AT TYR-216 AND TYR-241,
RP   AND MUTAGENESIS OF TYR-216 AND TYR-241.
RX   PubMed=20526344; DOI=10.1038/ni.1886;
RA   Hitomi K., Tahara-Hanaoka S., Someya S., Fujiki A., Tada H., Sugiyama T.,
RA   Shibayama S., Shibuya K., Shibuya A.;
RT   "An immunoglobulin-like receptor, Allergin-1, inhibits immunoglobulin E-
RT   mediated immediate hypersensitivity reactions.";
RL   Nat. Immunol. 11:601-607(2010).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=C57BL/6J, and NOD; TISSUE=Bone marrow, and Colon;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-216 AND TYR-241, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006;
RA   Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,
RA   Thibault P.;
RT   "The phagosomal proteome in interferon-gamma-activated macrophages.";
RL   Immunity 30:143-154(2009).
CC   -!- FUNCTION: Immunoglobulin-like receptor which plays an inhibitory role
CC       in degranulation of mast cells. Negatively regulates IgE-mediated mast
CC       cell activation and suppresses the type I immediate hypersensitivity
CC       reaction. {ECO:0000269|PubMed:20526344}.
CC   -!- SUBUNIT: Monomer (Probable). Interacts (tyrosine-phosphorylated) with
CC       PTPN6, PTPN11 and INPP5D. {ECO:0000269|PubMed:20526344, ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:20526344};
CC       Single-pass type I membrane protein {ECO:0000269|PubMed:20526344}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Secreted {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q3TB92-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q3TB92-2; Sequence=VSP_028742;
CC   -!- TISSUE SPECIFICITY: Expressed in myeloid cells (dendritic cells,
CC       macrophages and neutrophils but not in T-cells, B-cells or natural
CC       killer cells) and mast cells (at protein level).
CC       {ECO:0000269|PubMed:20526344}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:20526344}.
CC   -!- DISRUPTION PHENOTYPE: Enhanced IgE-mediated, mast cell-dependent
CC       passive systemic anaphylaxis. No effect on differentiation of
CC       hematopoietic cells, including mast cells.
CC       {ECO:0000269|PubMed:20526344}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAE32051.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB542953; BAJ08254.1; -; mRNA.
DR   EMBL; AK136488; BAE23003.1; -; mRNA.
DR   EMBL; AK151814; BAE30712.1; -; mRNA.
DR   EMBL; AK153506; BAE32051.1; ALT_INIT; mRNA.
DR   EMBL; AK169925; BAE41463.1; -; mRNA.
DR   EMBL; AK170947; BAE42134.1; -; mRNA.
DR   EMBL; AK171381; BAE42422.1; -; mRNA.
DR   EMBL; BC139224; AAI39225.1; -; mRNA.
DR   EMBL; BC139225; AAI39226.1; -; mRNA.
DR   EMBL; BC145580; AAI45581.1; -; mRNA.
DR   CCDS; CCDS25560.1; -. [Q3TB92-1]
DR   CCDS; CCDS70335.1; -. [Q3TB92-2]
DR   RefSeq; NP_001028607.1; NM_001033435.3. [Q3TB92-1]
DR   RefSeq; NP_001258301.1; NM_001271372.1.
DR   RefSeq; NP_001258302.1; NM_001271373.1.
DR   RefSeq; NP_001258303.1; NM_001271374.1. [Q3TB92-2]
DR   RefSeq; NP_001258304.1; NM_001271375.1. [Q3TB92-2]
DR   RefSeq; XP_006533711.1; XM_006533648.3. [Q3TB92-1]
DR   RefSeq; XP_006533712.1; XM_006533649.3. [Q3TB92-2]
DR   RefSeq; XP_011247406.1; XM_011249104.2. [Q3TB92-1]
DR   AlphaFoldDB; Q3TB92; -.
DR   SMR; Q3TB92; -.
DR   DIP; DIP-62112N; -.
DR   STRING; 10090.ENSMUSP00000083538; -.
DR   GlyGen; Q3TB92; 1 site.
DR   iPTMnet; Q3TB92; -.
DR   PhosphoSitePlus; Q3TB92; -.
DR   EPD; Q3TB92; -.
DR   MaxQB; Q3TB92; -.
DR   PaxDb; Q3TB92; -.
DR   PeptideAtlas; Q3TB92; -.
DR   PRIDE; Q3TB92; -.
DR   ProteomicsDB; 290081; -. [Q3TB92-1]
DR   ProteomicsDB; 290082; -. [Q3TB92-2]
DR   Antibodypedia; 68852; 110 antibodies from 14 providers.
DR   Ensembl; ENSMUST00000086353; ENSMUSP00000083538; ENSMUSG00000040528. [Q3TB92-1]
DR   Ensembl; ENSMUST00000147326; ENSMUSP00000138742; ENSMUSG00000040528. [Q3TB92-1]
DR   Ensembl; ENSMUST00000182908; ENSMUSP00000138678; ENSMUSG00000040528. [Q3TB92-2]
DR   Ensembl; ENSMUST00000183111; ENSMUSP00000138513; ENSMUSG00000040528. [Q3TB92-2]
DR   GeneID; 380732; -.
DR   KEGG; mmu:380732; -.
DR   UCSC; uc007lzj.2; mouse. [Q3TB92-1]
DR   UCSC; uc007lzl.2; mouse. [Q3TB92-2]
DR   CTD; 284021; -.
DR   MGI; MGI:2685731; Milr1.
DR   VEuPathDB; HostDB:ENSMUSG00000040528; -.
DR   eggNOG; ENOG502S5BW; Eukaryota.
DR   GeneTree; ENSGT01050000244988; -.
DR   InParanoid; Q3TB92; -.
DR   OMA; ENVCKDQ; -.
DR   OrthoDB; 1405395at2759; -.
DR   BioGRID-ORCS; 380732; 1 hit in 70 CRISPR screens.
DR   PRO; PR:Q3TB92; -.
DR   Proteomes; UP000000589; Chromosome 11.
DR   RNAct; Q3TB92; protein.
DR   Bgee; ENSMUSG00000040528; Expressed in granulocyte and 77 other tissues.
DR   ExpressionAtlas; Q3TB92; baseline and differential.
DR   Genevisible; Q3TB92; MM.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; IBA:GO_Central.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0098742; P:cell-cell adhesion via plasma-membrane adhesion molecules; IBA:GO_Central.
DR   GO; GO:0043303; P:mast cell degranulation; IMP:UniProtKB.
DR   GO; GO:0033004; P:negative regulation of mast cell activation; IMP:UniProtKB.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR029626; Allergin-1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   PANTHER; PTHR11481:SF58; PTHR11481:SF58; 2.
DR   Pfam; PF13895; Ig_2; 1.
DR   SMART; SM00409; IG; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Disulfide bond; Glycoprotein;
KW   Immunoglobulin domain; Membrane; Phosphoprotein; Reference proteome;
KW   Secreted; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..33
FT                   /evidence="ECO:0000255"
FT   CHAIN           34..246
FT                   /note="Allergin-1"
FT                   /id="PRO_0000307365"
FT   TOPO_DOM        34..150
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        151..171
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        172..246
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          52..131
FT                   /note="Ig-like C2-type"
FT   MOTIF           214..219
FT                   /note="ITIM motif"
FT   MOTIF           239..244
FT                   /note="ITIM motif"
FT   MOD_RES         216
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:20526344,
FT                   ECO:0007744|PubMed:19144319"
FT   MOD_RES         241
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:20526344,
FT                   ECO:0007744|PubMed:19144319"
FT   CARBOHYD        68
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        73..120
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         140..178
FT                   /note="KDESCPSCRLSLLLPGLLLGILVIVLVLAYLIHLKYKKG -> R (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:16141072"
FT                   /id="VSP_028742"
FT   MUTAGEN         216
FT                   /note="Y->F: Abolishes interaction with PTPN6 and PTPN11.
FT                   Loss of function; when associated with F-241."
FT                   /evidence="ECO:0000269|PubMed:20526344"
FT   MUTAGEN         241
FT                   /note="Y->F: Abolishes interaction with PTPN6 and PTPN11.
FT                   Loss of function; when associated with F-216."
FT                   /evidence="ECO:0000269|PubMed:20526344"
FT   CONFLICT        13
FT                   /note="V -> F (in Ref. 2; BAE32051)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        104
FT                   /note="D -> E (in Ref. 2; BAE30712)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        140..141
FT                   /note="KD -> N (in Ref. 2; BAE42422)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   246 AA;  27366 MW;  38B4E4EE9E229B49 CRC64;
     MGDGDSPMCL SAVSFKGIRC WLDKLLLWAL TISITLQNAA VDCTRVENNE LPSPNLNSSM
     NVVRMGQNVS LSCSTKNTSV DITYSLFWGT KYLESKRRRG GAVDFHLRIS NANESGPYKC
     KVNVSNLMKY SQDFNFTMAK DESCPSCRLS LLLPGLLLGI LVIVLVLAYL IHLKYKKGKK
     TQREDQSKGS GDAPAQDELY VNACKTQTEQ PQEIHYATPV FKEMAPMEEE GGTDGKADYI
     YSELTH
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024